Floatz logo

Therapeutic Asset Ratings

13,150 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Atezolizumab
Plasma Cell Myeloma
Genentech, Inc.P2CCC (55)
Atezolizumab
Ureter Cancer
National Cancer Institute (NCI)P2CCC (55)
Atezolizumab
Urethra Cancer
National Cancer Institute (NCI)P2CCC (55)
Atorvastatin
Depressive Disorder
Tanta UniversityP2CCC (55)
Autologous Conditioned Plasma
Osteoarthritis, Spine
Allmed Medical CenterP2CCC (55)
AVOLVE
Prostate Neoplasm
CHU de Quebec-Universite LavalP2CCC (55)
axa1125
Long COVID-19
Axcella Health, IncP2CCC (55)
Azacitidine
Bilineal Acute Myeloid Leukemia
M.D. Anderson Cancer CenterP2CCC (55)
Azacitidine
Breast Cancer
National University Hospital, SingaporeP2CCC (55)
Azacitidine
Chronic Myeloid Leukemia
The First Affiliated Hospital of Soochow UniversityP2CCC (55)
Azacitidine
Breast Carcinoma
University of Illinois at ChicagoP2CCC (55)
Azacitidine
Plasma Cell Myeloma
Sumitomo Pharma America, Inc.P2CCC (55)
Azacitidine
Childhood Acute Myeloid Leukemia
Children's Hospital of Soochow UniversityP2CCC (55)
Bacillus Calmette-Guerin Live Antigen, Unspecified Substrain
Dementia
Steven E Arnold, MDP2CCC (55)
Basimglurant
Tuberous Sclerosis
Noema Pharma AGP2CCC (55)
bay2395840
Peripheral Neuropathy
BayerP2CCC (55)
Bbt-877
Idiopathic Pulmonary Fibrosis
Bridge Biotherapeutics, Inc.P2CCC (55)
Beclomethasone
Long COVID-19
Duke UniversityP2CCC (55)
Befiradol
Drug-Induced Dyskinesia
Neurolixis SASP2CCC (55)
Bemnifosbuvir
Chronic Hepatitis C Virus Infection
Atea Pharmaceuticals, Inc.P2CCC (55)
Bemnifosbuvir
Cirrhosis Of Liver
Atea Pharmaceuticals, Inc.P2CCC (55)
Bemnifosbuvir
Hepatitis C Virus Infection
Atea Pharmaceuticals, Inc.P2CCC (55)
Bendamustine
Primary Central Nervous System Lymphoma
Miltenyi Biomedicine GmbHP2CCC (55)
bi 770371
Cirrhosis Of Liver
Boehringer IngelheimP2CCC (55)
Biib091
Multiple Sclerosis
BiogenP2CCC (55)
Showing 2626 to 2650 of 13,150 assets
PreviousPage 106 of 526Next